XML 54 R35.htm IDEA: XBRL DOCUMENT v3.22.1
SHAREHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Assumptions Used to Estimate Fair Value

The fair value of the Company's stock options granted for the years ended December 31, 2021, 2020 and 2019 was estimated using the following weighted average assumptions:

Year ended December 31,

2021

2020

2019

 

Risk free interest

0.26%-1.14%

-

1.35%-2.51%

Dividend yields

0%

-

0%

Volatility

41.09%-50.62%

-

33.35%-34.32%

Expected term (in years)

4.00-4.04

-

4.22-4.26

Schedule of Stock-Based Compensation Expenses

During the year ended December 31, 2021, 2020 and 2019 the stock-based compensation for options were recognized in the consolidated statement of income (loss) in the following line items:

Year ended December 31,

2021

2020

2019

 

Cost of revenues of products

$

137

$

82

$

138

Cost of revenues of services

140

84

120

Research and development, net

304

279

280

Selling and marketing

422

287

448

General and administrative

301

550

1,149

$

1,304

$

1,282

$

2,135

Employee [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Stock Option Activity

A summary of employee option balances under the 2008 Plan as of December 31, 2021 and changes during the year then ended are as follows:

Number of options

Weighted-average

exercise

price *)

Weighted- average

remaining

contractual term

(in years)

Aggregate intrinsic

value

(in thousands)

*)

 

Outstanding at January 1, 2021

2,776,778

$

6.1

3.0

$

4,142

 

Granted

2,422,500

$

8.1

Exercised

(1,391,384

)

$

4.6

Forfeited and cancelled

(708,750

)

$

8.0

 

Outstanding as of December 31, 2021

3,099,144

$

7.8

4.5

$

1,737

 

Exercisable as of December 31, 2021

434,769

$

6.4

2.3

$

504

*) In January 2021 the Company distributed a cash dividend in the amount of $35,003 or $0.63 per share. All exercise prices were updated on a retrospective basis (See Note 11.c)

Schedule of Stock Option Activity by Exercise Price

The outstanding and exercisable options granted under the 2008 Plan as of December 31, 2021, have been separated into ranges of exercise price as follows:

Ranges of

exercise

price

Options

outstanding

as of

December 31,

2021

Weighted

average

remaining

contractual

life (in years)

Weighted

average

exercise

price

Options

exercisable

as of

December 31,

2021

Weighted

average exercise

price of

exercisable

options

 

$3.51-5.07

137,893

0.7

$

3.8

137,893

3.8

$6.22-8.52

2,161,251

4.5

$

6.7

296,876

7.6

$9.92-11.92

800,000

5.3

$

11.5

-

-

 

3,099,144

4.5

$

7.8

434,769

6.4